Literature DB >> 26916972

Better understanding of the health care costs of lung cancer and the implications.

Reiner Leidl1, Margarethe Wacker1, Larissa Schwarzkopf1.   

Abstract

Entities:  

Year:  2016        PMID： 26916972     DOI： 10.1586/17476348.2016.1149064

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN： 1747-6348            Impact factor:   3.772


× No keyword cloud information.
  4 in total

1.  Referring patients with suspected lung cancer: a qualitative study with primary healthcare professionals in Ireland.

Authors:  Mohamad M Saab; Michelle O'Driscoll; Serena FitzGerald; Laura J Sahm; Patricia Leahy-Warren; Brendan Noonan; Caroline Kilty; Maria O'Malley; Noreen Lyons; Heather E Burns; Una Kennedy; Áine Lyng; Josephine Hegarty
Journal:  Health Promot Int       Date:  2022-06-01       Impact factor: 3.734

2.  Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe.

Authors:  Katharina Verleger; John R Penrod; Melinda Manley Daumont; Caitlyn Solem; Linlin Luo; Cynthia Macahilig; Nadine Hertel
Journal:  Clinicoecon Outcomes Res       Date:  2020-01-15

3.  Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.

Authors:  Manuel B Huber; Maximilian Präger; Kathryn Coyle; Doug Coyle; Adam Lester-George; Marta Trapero-Bertran; Bertalan Nemeth; Kei Long Cheung; Renee Stark; Matthias Vogl; Subhash Pokhrel; Reiner Leidl
Journal:  Addiction       Date:  2017-12-15       Impact factor: 6.526

4.  SRCIN1 Regulated by circCCDC66/miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer.

Authors:  Weijun Hong; Suyun Yu; Yaqing Zhuang; Qingqing Zhang; Jiqin Wang; Xiwen Gao
Journal:  Biomed Res Int       Date:  2020-09-09       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.